CIK 0001321732
- Large accelerated filer
Penumbra Inc
Sign in to watch- Ticker
- PEN
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-995-2486
- Business address
- ONE PENUMBRA PLACE, ALAMEDA, CA, 94502
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 66 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-02-13 | Elsesser Adam Chairman, CEO and President | Sale | −400 | $73.44 | $29K | 1,236,038 |
| 2017-02-13 | Elsesser Adam Chairman, CEO and President | Sale | −200 | $74.33 | $15K | 1,235,838 |
| 2017-02-13 | Elsesser Adam Chairman, CEO and President | Option exercise · Stock Option (right to buy) | −1,600 | 0 | ||
| 2017-02-13 | Pray James Robert President, International | Sale | −1,000 | $72.52 | $73K | 543,778 |
| 2017-02-13 | Pray James Robert President, International | Sale | −500 | $73.50 | $37K | 543,278 |
| 2017-02-13 | Pray James Robert President, International | Sale | −200 | $74.50 | $15K | 543,078 |
| 2017-02-13 | Kosaraju Sridhar CFO and Head of Strategy | Sale | −800 | $72.35 | $58K | 490,407 |
| 2017-02-13 | Kosaraju Sridhar CFO and Head of Strategy | Sale | −600 | $73.28 | $44K | 489,807 |
| 2017-02-13 | Kosaraju Sridhar CFO and Head of Strategy | Sale | −200 | $74.30 | $15K | 489,607 |
| 2017-02-10 | Davis Daniel Donen President, North America | Option exercise | +2,200 | $12.36 | $27K | 46,141 |
| 2017-02-10 | Davis Daniel Donen President, North America | Sale | −200 | $70.70 | $14K | 45,941 |
| 2017-02-10 | Davis Daniel Donen President, North America | Sale | −1,998 | $72.05 | $144K | 43,943 |
| 2017-02-10 | Davis Daniel Donen President, North America | Sale | −2 | $72.40 | $145 | 43,941 |
| 2017-02-10 | Davis Daniel Donen President, North America | Option exercise · Stock Option (right to buy) | −2,200 | 191,376 | ||
| 2017-02-10 | Bose Arani Chief Innovator | Option exercise | +6,100 | $1.26 | $8K | 738,291 |
| 2017-02-10 | Bose Arani Chief Innovator | Sale | −500 | $71.03 | $36K | 737,791 |
| 2017-02-10 | Bose Arani Chief Innovator | Sale | −5,600 | $72.10 | $404K | 732,191 |
| 2017-02-10 | Bose Arani Chief Innovator | Option exercise · Stock Option (right to buy) | −6,100 | 1,600 | ||
| 2017-02-10 | Elsesser Adam Chairman, CEO and President | Option exercise | +6,100 | $1.26 | $8K | 1,241,938 |
| 2017-02-10 | Elsesser Adam Chairman, CEO and President | Sale | −400 | $71.00 | $28K | 1,241,538 |
Page 82 of 88 · 1,759 trades